alztev 13.3/24 transdermal patch
teva pharma b.v. - rivastigmine base - transdermal patch - 13.3/24 - anticholinesterases
emerpand 4.6 mg/24 hours transdermal patch
actavis group ptc ehf - rivastigmine - transdermal patch - 4.6 mg/24 hours - anticholinesterases
emerpand 9.5 mg/24 hours transdermal patch
actavis group ptc ehf - rivastigmine - transdermal patch - 9.5 mg/24 hours - anticholinesterases
emerpand 13.3 mg/24 hours transdermal patch
actavis group ptc ehf - rivastigmine - transdermal patch - 13.3 mg/24 hours - anticholinesterases
nimvastid
krka, d.d., novo mesto - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia. symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.,
rivastigmine 1 a pharma
1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
rivastigmine hexal
hexal ag - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
rivastigmine sandoz
sandoz gmbh - rivastigmine - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
rivastigmine actavis
actavis group ptc ehf - rivastigmine hydrogen tartrate - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
exelon 4.6mg24hours transdermal patches
novartis pharmaceuticals uk ltd - rivastigmine - transdermal patch - 4.6mg/24hour